Clinical Trial Update: A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

Phase 3 study to evaluate astegolimab in patients with chronic obstructive pulmonary disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Astegolimab (astegolimab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: RECRUITING